Skip to Content
Søk Menu
cncpt-artikel_lb_atf

The 2024 ASCO Genitourinary Cancers Symposium Will Be Covered by BestPractice Nordic

In 2024, BestPractice Nordic will cover the ASCO Genitourinary Cancers Symposium live from the congress.

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Relaterat innehåll

Continued Progress for the Treatment of Gynecological Cancer But No Game-Changer

/ BestPractice Nordic
ESMO24Gynekologisk cancer

The Choice of Immunotherapy and PARP Inhibitor for Gynecological Cancer

/ BestPractice Nordic
ESMO24Gynekologisk cancer
Mansoor Raza Mirza

ESMO 2024: Hope and Disappointment for Ovarian Cancer Treatment

/ Mansoor Raza Mirza
ESMO24Gynekologisk cancer Play the Video 09:55

ESMO24: New Standard of Care – Immunotherapy in High-Risk Locally Advanced Cervical Cancer

/ Jan Andreasen
ESMO24Gynekologisk cancer
Mansoor Raza Mirza

ESMO: Update on the ENGOT-EN6 RUBY Trial

/ Mansoor Raza Mirza
ESMO24Gynekologisk cancer Play the Video 02:46
Mansoor Raza Mirza

Mansoor Raza Mirza: ESMO is the Meeting Which Brings New Data for Forever Practice-Changing Trials

/ Mansoor Raza Mirza
ESMO24Gynekologisk cancer Play the Video 04:00
Marc Eid og Karl Semaan

Cancer Epigenomics Improve the Overall Survival and the Quality of Life

/ Marc Eid / Karl Semaan
ASCOGU24Prostatacancer Play the Video 1:31
Wadih Issa

Comparing Downstaging in RCC-Patients with Tumor or Without Tumor Thrombus Receiving Neoadjuvant ICI Regimen

/ Wadih Issa
ASCOGU24Njurcancer Play the Video 1:47
Eddy Saad

Understanding Mechanisms Behind Acquired Resistance to Immunotherapy in Metastatic Renal Cell Carcinoma

/ Eddy Saad
ASCOGU24Njurcancer Play the Video 2:21
Back to top